Febrile neutropenia: transition towards a risk-directed approach.
Anoop
P
P
Anjay
M A
MA
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D005334:Fever / Q000188:drug therapy*; D006801:Humans; D009503:Neutropenia / Q000150:complications*; D018579:Patient Selection; D018570:Risk Assessment
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents